On January 28, 2020, OncoSec Medical Incorporated announced that it is texting to ask shareholders to vote yes on the Company’s proxy card for the strategic transaction with China Grand Pharma and Sirtex, which provides an immediate and crucial $30 million cash infusion at a premium and eliminates the need to raise capital for the foreseeable future.